p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R, Ikawa S, Maeda T, Nakazaki Y, Kurita R, Harata M, Shutoh Y, Bai YS, Soda Y, Tanabe T, Dohi T, Kato R, Ikawa Y, Asano S, Tani K.
Kunisaki R, et al. Among authors: kato r.
J Gene Med. 2006 Sep;8(9):1121-30. doi: 10.1002/jgm.945.
J Gene Med. 2006.
PMID: 16832836